<unk>  is a antifungal,  anti-Infective Agent,  antiprotozoal ,  Dermatological Agent and Polyene that is FDA approved for the treatment of invasive aspergillosis, cryptococcosis (torulosis), North American blastomycosis, systemic candidiasis, coccidioidomycosis, histoplasmosis, zygomycosis including mucormycosis due to susceptible species of the genera<unk> sidia, Mucor and Rhizopus, and infections due to related susceptible species of Conidiobolus and Basidiobolus, and sporotrichosis.<unk>  may be useful in the treatment of American mucocutaneous leishmaniasis, but it is not the drug of choice as primary therapy.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hypotension, thrombophlebitis, injection site pain, diarrhea, indigestion, loss of appetite, nausea, vomiting, normocystic normochromic anemia, arthralgia, myalgia, headache, tachypnea, fever, malaise, and shivering.
The drug is available as conventional<unk> <unk>  deoxycholate;<unk> -d) or as lipid-based formulations.  Available lipid-based formulations include<unk>  Lipid Complex <unk> LC;<unk> elcet),<unk>  cholesteryl sulfate complex<unk>  Colloidal Dispersion;<unk> CD;<unk> tec), and Liposomal<unk>  (LAmB;<unk> isome).
Amphotericin B
Terbinafine 
Voriconazole 
Fluconazole 
Miconazole 
Dapsone 
Caspofungin
Ipriflavone